WELL Health Technologies Corp. Strikes Another Deal
WELL Health Technologies Corp., the Canadian digital health company, has announced a new deal for Aware MD based in Ontario. The deal is valued at CAD 4.5 million, or roughly $3.6 million. The deal also includes a conditional earn-out based on the overall operating performance of Aware MD of up to $2.7 million. In 2020, Aware MD generated $1.58 million in revenue. Aware MD is an enterprise-class electronic medical records (EMR) provider with an array of products and services for disease specialties including cardiology, radiology, endocrinology, and rheumatology. Aware MD developed the Cerebrum proprietary workflow solution designed for specialists to manage busy and multi-diagnostic... Read More »
WELL Health Technologies Corp. Acquires wisp
The digital health provider WELL Health Technologies Corp. has announced a new deal for Silicon Valley-based wisp, Inc. (WISP). WELL Health is a prolific strategic buyer in the healthcare M&A market (20 deals over three years) and has a robust network of clinics and telehealth operations in British Columbia, but has been making moves in the United States recently. The deal for WISP is valued at approximately $41 million, comprised of $27.7 million in cash and $6.2 million in WELL Health shares. WELL Health is acquiring roughly 53% of WISP, and the transaction includes a multi-year performance earnout up to a maximum of $7.4 million. WISP is a leading national provider of telehealth... Read More »
Equity Consortium Takes Inovalon Private
A group of private equity buyers has announced an agreement to acquire Inovalon, taking the publicly traded digital health company private. The group is led by Nordic Capital and joined by Insight Partners as lead co-investor, with 22C Capital, Inovalon founder/Chief Executive Officer Keith Dunleavy and certain Class B stockholders of Inovalon joining in on the investment. The deal is valued at $7.3 billion in an all-cash transaction. Inovalon stockholders will receive $41.00 per share in cash for each share of Class A Common Stock or Class B Common Stock. The company provides cloud-based platforms empowering data-driven healthcare. Through the Inovalon ONE Platform, it brings a... Read More »
Alphabet Subsidiary Verily Acquires SignalPath
Alphabet (Google) is making another move into the healthcare space. Verily, its life sciences research platform and subsidiary, has announced an agreement to acquire SignalPath for an undisclosed sum. SignalPath is a privately held company that has developed the SignalPath platform, a clinical trial management system (CTMS) that improves the ease, quality and efficiency of conducting clinical research at study sites. SignalPath’s platform reduces fragmentation by leveraging a modern software architecture with a cloud-based platform to optimize the management of a study site’s clinical trials portfolio. SignalPath’s robust technology infrastructure offers novel approaches... Read More »
Labcorp Expands Presence in Women’s Health
The global life sciences company Labcorp has announced the acquisition of Ovia Health, a digital health platform focused exclusively on women’s health. No specific financial terms were disclosed. Although Ovia highlights its health application for individual patients that provide daily, personalized family health support and data feedback to guide them through pregnancy, the company also works with employers and health plans. For employers, Ovia offers a platform that integrates within the company’s family benefits ecosystem, offering health plan care management, fertility and family building benefits, onsite and virtual care, patient engagement programs and more. On Ovia’s website,... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
